Aelis Farma SA
PAR:AELIS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Aelis Farma SA
PAR:AELIS
|
FR |
|
Blue Owl Capital Corp
NYSE:OBDC
|
US |
|
S
|
ScreenPro Security Inc
CNSX:SCRN
|
CA |
|
Kratos Defense and Security Solutions Inc
NASDAQ:KTOS
|
US |
|
L
|
Landmark Property Development Co Ltd
NSE:LPDC
|
IN |
|
Af Gruppen ASA
OTC:AGRUF
|
NO |
|
S
|
Skin N Skin Co Ltd
KOSDAQ:159910
|
KR |
|
Kerala Ayurveda Ltd
BSE:530163
|
IN |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is AELIS's stock price target?
Not Available
AELIS doesn't have any price targets made by Wall Street professionals.
What is Aelis Farma SA's Revenue forecast?
Projected CAGR
162%
The compound annual growth rate of Aelis Farma SA's revenue for the next 3 years is 162%.